03 Feb 2021 VUB scientist Mathieu Vinken coordinates prestigious European research into animal-free methods for testing chemical substances Member news
02 Feb 2021 argenx announces “GO” Decision in ADHERE trial of Efgartigimod in Chronic Inflammatory Demyelinating Polyneuropathy following interim analysis Member news
14 Jan 2021 Bone Therapeutics and Rigenerand sign partnership for cell therapy process development Member news
12 Jan 2021 Bone Therapeutics treats first patient in ALLOB Phase IIb tibial fracture study Member news
07 Jan 2021 argenx and Zai Lab announce strategic collaboration for Efgartigimod in Greater China Member news
23 Dec 2020 Richter and Mithra strengthen their partnership and signed a license and supply agreement for the commercialization of Estelle® to Latin America Member news
22 Dec 2020 Bone Therapeutics completes recruitment and patient treatment in JTA-004 pivotal Phase III knee osteoarthritis study Member news
18 Dec 2020 ONA Therapeutics, Absolute Antibody and RIC partner to create new type of biologic Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
